跳至主要内容
临床试验/NCT06976359
NCT06976359已完成不适用

The National Health and Nutrition Examination Survey

Kunming Children's Hospital1 个研究点 分布在 1 个国家目标入组 3,988 人开始时间: 2025年4月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,988
试验地点
1
主要终点
mortality

研究概览

简要总结

Based on retrospective cohort data from 3,988 diabetic patients in the NHANES database, this study is the first to show a significant negative correlation between the CALLY index and all-cause mortality in diabetic patients, with good predictive ability for their survival risk. Our findings can help clinicians better assess disease progression in diabetic patients and provide a reference for personalized, precision medicine.

详细描述

All analyses accounted for NHANES sample weights, clustering, and stratification. We used EmpowerStats (v4.1, www.empowerstats.com) and R software (v4.4.1, www.r-project.org). Continuous variables were expressed as weighted mean ± standard error (SE), and categorical variables as weighted percentages. Associations between the CALLY index and all-cause mortality were assessed using Cox proportional hazards models. Model 1 was the unadjusted crude model. Model 2 included adjustments for age, sex, race, BMI, PIR, education, smoking, and alcohol consumption. Model 3 was the fully adjusted model including additional covariates, HDL, TC, BUN, uric acid, SCR, physical activity, energy intake, hypertension, CVD. Kaplan-Meier survival curves were used to compare survival across CALLY quartiles; differences were assessed using log-rank tests. Nonlinear associations were examined with smoothed curve fitting. Subgroup analyses explored consistency across strata. ROC curves and AUC were used to compare the predictive performance of CALLY, SII, PLR, and NLR. P < 0.05 was considered statistically significant.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) self-reported doctor-diagnosed diabetes; (2) fasting blood glucose ≥ 7.0 mmol/L; (3) two-hour oral glucose tolerance test blood glucose ≥ 11.1 mmol/L; (4) glycated hemoglobin A1c (HbA1c) ≥ 6.5%; or (5) use of hypoglycemic medication.

排除标准

  • 未提供

结局指标

主要结局

mortality

时间窗: 2025-5-8

all-cause mortality

次要结局

未报告次要终点

研究者

发起方
Kunming Children's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhu Tian

clinician

Kunming Children's Hospital

研究点 (1)

Loading locations...

相似试验